Advances in preclinical models for pediatric diffuse intrinsic pontine glioma
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70275 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Bieke Van den Ende und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, Katholieke Universiteit Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Diffuse Intrinsic Pontine Glioma, Brain Stem Neoplasms, Disease Models, Animal. Die Arbeit nennt 129 Literaturangaben.
Abstract (Originalsprache)
Diffuse intrinsic pontine gliomas (DIPG) are highly aggressive brainstem tumors, representing the leading cause of pediatric cancer‐related mortality despite their rarity. DIPGs are predominantly characterized by the H3K27M mutation, which drives tumorigenesis through epigenomic reprogramming and dysregulated gene expression. A major barrier to therapeutic advancement has been the scarcity of representative preclinical models, historically limited by the rarity of tumor tissue samples. Recent advancements in biopsy safety and model development have accelerated progress in understanding DIPG biology and developing novel therapies. While current murine models offer valuable insights, they often fail to replicate the tumor's genetic and microenvironmental complexity fully. Non‐murine models offer cost‐effective platforms but are limited by anatomical and immunological differences that reduce their relevance to human DIPG. This review highlights advances and limitations in DIPG models, emphasizing the need for integrative approaches using multiple systems to validate therapies, as no single model can fully capture the disease's complexity. Addressing these gaps could lead to the development of novel treatments for DIPG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, Katholieke Universiteit Leuven, Leuven, Belgium.
- Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
- The KU Leuven Institute for Single-Cell Omics (LISCO), KU Leuven, Leuven, Belgium.
- Department of Pediatric Hemato-Oncology, University Hospitals Leuven, Leuven, Belgium.
- Department of Oncology, Pediatric Oncology, Katholieke Universiteit Leuven, Leuven, Belgium.
- Department of Neurosurgery, CHU UCL Namur Site Godinne, Université Catholique de Louvain, Ottignies-Louvain-la-Neuve, Belgium.
ORCID-Profile: Bieke Van den Ende, Matteo Riva
Zitieren
APA
Van den Ende, B., de Smet, F., Jacobs, S., Coosemans, A., & Riva, M. (2026). Advances in preclinical models for pediatric diffuse intrinsic pontine glioma. International Journal of Cancer. https://doi.org/10.1002/ijc.70275
Vancouver
Van den Ende B, de Smet F, Jacobs S, Coosemans A, Riva M. Advances in preclinical models for pediatric diffuse intrinsic pontine glioma. International Journal of Cancer. 2026. doi:10.1002/ijc.70275
BibTeX
@article{VandenEnde2026,
author = {Van den Ende, Bieke and de Smet, Frederik and Jacobs, Sandra and Coosemans, An and Riva, Matteo},
title = {Advances in preclinical models for pediatric diffuse intrinsic pontine glioma},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70275}
}
EUVIMED